SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syngene International incorporates wholly owned subsidiary

29 Aug 2022 Evaluate

Syngene International has incorporated wholly owned subsidiary company namely ‘Syngene Manufacturing Solutions’ (SMSL) on August 26, 2022. SMSL shall be engaged in the business of manufacturing of pharmaceutical, biopharmaceutical and biological products of any kind. The company has acquired is 10 lakh equity shares of Rs 10 each aggregating to Rs 1 crore.  

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene Internation. Share Price

436.55 0.85 (0.20%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 436.55
Indegene 482.65
CMS Info Systems 317.60
JITF Infralogistics 331.25
Sagility 42.17
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×